Amaan Bari

The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease

A. Yan, K. Connelly, C. Mazer, 2023, Diabetes, obesity & metabolism.